Welcome to LookChem.com Sign In|Join Free

CAS

  • or

180976-98-1

Post Buying Request

180976-98-1 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

180976-98-1 Usage

Description

BOC-4-AMINO-3-METHOXYBENZOIC ACID is a chemical compound with the molecular formula C11H13NO4, belonging to the benzoic acid derivatives. It features a Boc (tert-butoxycarbonyl) protecting group attached to the amino group, which is crucial for its stability and reactivity in various chemical reactions. BOC-4-AMINO-3-METHOXYBENZOIC ACID serves as a versatile building block in the synthesis of pharmaceuticals, agrochemicals, and specialty chemicals, playing a significant role in medicinal chemistry and drug discovery due to its ability to form biologically active compounds.

Uses

Used in Pharmaceutical Industry:
BOC-4-AMINO-3-METHOXYBENZOIC ACID is used as a key intermediate in the synthesis of various pharmaceuticals for its ability to form biologically active compounds. Its presence in the molecular structure of target drugs contributes to their therapeutic effects, making it an essential component in drug development.
Used in Agrochemical Industry:
In the agrochemical sector, BOC-4-AMINO-3-METHOXYBENZOIC ACID is utilized as a building block in the production of agrochemicals, such as pesticides and herbicides. Its incorporation into these compounds enhances their effectiveness in controlling pests and weeds, thereby improving crop yields and quality.
Used in Specialty Chemicals Industry:
BOC-4-AMINO-3-METHOXYBENZOIC ACID is employed in the synthesis of specialty chemicals, which are high-value chemicals used in various applications, such as fragrances, dyes, and coatings. Its unique chemical properties allow it to contribute to the desired characteristics of these specialty chemicals, making it a valuable component in their production.
Used in Medicinal Chemistry Research:
BOC-4-AMINO-3-METHOXYBENZOIC ACID is used as a research compound in medicinal chemistry, where it serves as a starting material or a building block for the development of new drugs and drug candidates. Its reactivity and the presence of the Boc protecting group make it suitable for various synthetic routes and chemical modifications, facilitating the exploration of novel therapeutic agents.
Used in Drug Discovery:
In the field of drug discovery, BOC-4-AMINO-3-METHOXYBENZOIC ACID is utilized as a key intermediate in the synthesis of potential drug candidates. Its ability to form biologically active compounds makes it a valuable asset in the search for new treatments and therapies for various diseases and conditions.

Check Digit Verification of cas no

The CAS Registry Mumber 180976-98-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,8,0,9,7 and 6 respectively; the second part has 2 digits, 9 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 180976-98:
(8*1)+(7*8)+(6*0)+(5*9)+(4*7)+(3*6)+(2*9)+(1*8)=181
181 % 10 = 1
So 180976-98-1 is a valid CAS Registry Number.

180976-98-1Relevant articles and documents

Synthesis and biological evaluation of 2,4-diaminopyrimidines as selective Aurora A kinase inhibitors

Qin, Wen-Wen,Sang, Chun-Yan,Zhang, Lin-Lin,Wei, Wei,Tian, Heng-Zhi,Liu, Huan-Xiang,Chen, Shi-Wu,Hui, Ling

, p. 174 - 184 (2015/03/31)

The Aurora kinases are a family of serine/threonine kinases that interact with components of the mitotic apparatus and serve as potential therapeutic targets in oncology. Here we synthesized 15 2,4-diaminopyrimidines and evaluated their biological activities, including antiproliferation, inhibition against Aurora kinases and cell cycle effects. These compounds generally exhibited more potent cytotoxicity against tumor cell lines compared with the VX-680 control, especially compound 11c, which showed the highest cytotoxicities, with IC50 values of 0.5-4.0 1/4M. Compound 11c had more than 35-fold more selectivity for Aurora A over Aurora B, and molecular docking analysis indicated that compound 11c form better interaction with Aurora A both from the perspective of structure and energy. Furthermore, compound 11c induced G2/M cell cycle arrest in HeLa cells. This series of compounds has the potential for further development as selective Aurora A inhibitors for anticancer activity.

Facile synthesis of benzamides to mimic an α-helix

Ahn, Jung-Mo,Han, Sun-Young

, p. 3543 - 3547 (2008/02/06)

A new α-helix mimetic was designed by using a benzamide as a rigid scaffold. It presents three functional groups corresponding to side chains of amino acids found at the i, i + 4, and i + 7 positions of an ideal α-helix, which are displayed on the same he

Inhibitors of prenyl transferases

-

, (2008/06/13)

Compounds which inhibit prenyl transferases, particularly farnysyltransferase and geranylgeranyl transferase I, processes for preparing the compounds, pharmaceutical compositions containing the compounds, and methods of use.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 180976-98-1